Priscilla Sugianto

Priscilla Sugianto is a physician-investor and Principal at Vivo Capital, where she focuses on advancing biopharma and digital health investments. She currently serves on the boards of directors for Inspirna, Adaxion Therapeutics, and Clasp Therapeutics, while previously holding board or observer roles at Ocelot Bio and Lenz Therapeutics. Before joining Vivo Capital, she worked as an Assistant Vice President at C-Bridge Capital, executing complex cross-border deals and contributing to the founding teams of Everest Medicines and AffaMed Therapeutics. Sugianto earned her MD from the Stanford University School of Medicine, an MBA from the Stanford Graduate School of Business, and a BS in Biochemistry summa cum laude from UCLA. Her diverse background also includes valuable digital health experience with Flare Capital and Doctor on Demand, alongside publishing peer-reviewed drug discovery research in prominent scientific journals like Cell Metabolism.